TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis

Biochemical and Biophysical Research Communications

Volumn 463, Issue 3, 2015, Pages 458-465

  Wang, Yi ^a   He, Du ^b   Yang, Liang ^c   Wen, Bo ^a   Dai, Jinfen ^d   Zhang, Qian ^e   Kang, Jian ^d   He, Weiyang ^e   Ding, Qianshan ^d   He, De ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Enshi Tujia and Miao Autonomous Prefecture   (China)

^c Qianjiang Central Hospital   (China)

^d RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^e WUHAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Prognosis; TRIM26; Tumor suppressor

Indexed keywords

TRIPARTITE MOTIF PROTEIN 26; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; TRIM26 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CELL INVASION; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; NEOPLASM INVASIVENESS; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84930931164     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.05.117     Document Type: Article

References (30)

1. Y. Kishi, K. Shimada, and S. Nara et al. Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma World J. Hepatol. 6 2014 836 843
2. K. Ikeda, and S. Inoue TRIM proteins as RING finger E3 ubiquitin ligases Adv. Exp. Med. Biol. 770 2012 27 37
3. J. Zhang, L. Fang, and X. Zhu et al. Ro52/SSA sensitizes cells to death receptor-induced apoptosis by down-regulating c-FLIP(L) Cell Biol. Int. 36 2012 463 468
4. J.C. Schwamborn, E. Berezikov, and J.A. Knoblich The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors Cell 136 2009 913 925
5. P.D. Uchil, T. Pawliczek, and T.D. Reynolds et al. TRIM15 is a focal adhesion protein that regulates focal adhesion disassembly J. Cell Sci. 127 2014 3928 3942
6. J.L. Bell, A. Malyukova, and M. Kavallaris et al. TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization Cell Cycle 12 2013 889 898
7. Y. Liu, R. Raheja, and N. Yeh et al. TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1) Oncogene 33 2014 308 315
8. L. Chen, D.T. Chen, and C. Kurtyka et al. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions J. Biol. Chem. 287 2012 40106 40118
9. K. Noguchi, F. Okumura, and N. Takahashi et al. TRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancers Carcinogenesis 32 2011 995 1004
10. T.W. Beck, J. Menninger, and W.J. Murphy et al. The feline major histocompatibility complex is rearranged by an inversion with a breakpoint in the distal class I region Immunogenetics 56 2005 702 709
11. W. Zhao, Q. Li, and S. Ayers et al. Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination Cell 152 2013 1037 1050
12. J.S. Lee, J.S. Bae, and J.H. Kim et al. Association study between TRIM26 polymorphisms and risk of aspirin-exacerbated respiratory disease Int. J. Mol. Med. 29 2012 927 933
13. R.A. Raposo, M. Abdel-Mohsen, and M. Bilska et al. Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells J. Virol. 87 2013 11924 11929
14. S. de Jong, K.R. van Eijk, and D.W. Zeegers et al. Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes Eur. J. Hum. Genet. 20 2012 1004 1008
15. S. Roessler, H.L. Jia, and A. Budhu et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients Cancer Res. 70 2010 10202 10212
16. T. Kawai, and S. Akira Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins EMBO Mol. Med. 3 2011 513 527
17. W.A. McEwan, and L.C. James TRIM21-dependent intracellular antibody neutralization of virus infection Prog. Mol. Biol. Transl. Sci. 129 2015 167 187
18. V. Cambiaghi, V. Giuliani, and S. Lombardi et al. TRIM proteins in cancer Adv. Exp. Med. Biol. 770 2012 77 91
19. F. Petrera Meroni G.TRIM proteins in development Adv. Exp. Med. Biol. 770 2012 131 141
20. O.H. Lee, J. Lee, and K.H. Lee et al. Role of the focal adhesion protein TRIM15 in colon cancer development Biochim. Biophys. Acta 1853 2015 409 421
21. N. Chen, S. Balasenthil, and J. Reuther et al. DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity Cancer Res. 74 2014 5683 5689
22. D. Jia, L. Wei, and W. Guo et al. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma Hepatology 54 2011 1227 1236
23. B. Herquel, K. Ouararhni, and K. Khetchoumian et al. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma Proc. Natl. Acad. Sci. U. S. A. 108 2011 8212 8217
24. T. Zheng, X. Hong, and J. Wang et al. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma Hepatology 59 2014 935 946
25. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
26. J. Razungles, V. Cavaillès, and S. Jalaguier et al. The Warburg effect: from theory to therapeutic applications in cancer Med. Sci. Paris. 29 2013 1026 1033
27. C. Mounier, L. Bouraoui, and E. Rassart Lipogenesis in cancer progression (review) Int. J. Oncol. 45 2014 485 492
28. C. Sebastian Tracking down the origin of cancer: metabolic reprogramming as a driver of stemness and tumorigenesis Crit. Rev. Oncog. 19 2014 363 382
29. Z. Derdak, N.M. Mark, and G. Beldi et al. The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells Cancer Res. 68 2008 2813 2819
30. N. Zaidi, J.V. Swinnen, and K. Smans ATP-citrate lyase: a key player in cancer metabolism Cancer Res. 72 2012 3709 3714